Biotechnology Stocks
| # | Ultimi 7 Giorni | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 834 |  MDGL Madrigal Pharmaceuticals, Inc. - Common Stock | 511.80 USD | -0.96% | -0.43% | -7.78% | +20.82% | 11.82 B USD | ||
| 861 |  TECH Bio-Techne Corp - Common Stock | 72.36 USD | +0.06% | -0.03% | +0.98% | +27.26% | 11.33 B USD | ||
| 876 |  AXSM Axsome Therapeutics, Inc. - Common Stock | 206.30 USD | -0.71% | -3.80% | -14.20% | +58.45% | 10.81 B USD | ||
| 886 |  CYTK Cytokinetics, Incorporated - Common Stock | 76.14 USD | -0.91% | +3.06% | -6.59% | +31.05% | 10.59 B USD | ||
| 898 |  SMMT Summit Therapeutics Inc. - Common Stock | 12.46 USD | -5.32% | +2.13% | -10.04% | -37.26% | 9.94 B USD | ||
| 899 |  PRAX Praxis Precision Medicines, Inc. - Common Stock | 365.98 USD | -2.65% | -3.34% | +12.51% | +658.98% | 10.22 B USD | ||
| 919 |  KRYS Krystal Biotech, Inc. - Common Stock | 344.62 USD | -0.57% | +3.76% | +1.63% | +84.16% | 10.20 B USD | ||
| 933 |  KNSA Kiniksa Pharmaceuticals International, plc - Class A Ordinary Shares | 78.54 USD | -0.62% | +1.02% | +24.75% | +98.08% | 9.99 B USD | ||
| 936 |  PTGX Protagonist Therapeutics, Inc. - Common Stock | 151.51 USD | -1.82% | -2.06% | +11.31% | +101.66% | 9.80 B USD | ||
| 938 |  KYMR Kymera Therapeutics, Inc. - Common Stock | 117.13 USD | -2.23% | -1.16% | +5.93% | +98.19% | 9.74 B USD | ||
| 940 |  IONS Ionis Pharmaceuticals, Inc. - Common Stock | 60.33 USD | +0.99% | +6.63% | +6.59% | -16.35% | 10.03 B USD | ||
| 963 |  SYRE Spyre Therapeutics, Inc. - Common Stock | 105.52 USD | -0.91% | +2.35% | +2.95% | +341.32% | 9.30 B USD | ||
| 969 |  PCVX Vaxcyte, Inc. - Common Stock | 61.46 USD | -1.85% | +3.87% | +12.21% | +45.30% | 9.15 B USD | ||
| 978 |  IMVT Immunovant, Inc. - Common Stock | 43.66 USD | -1.60% | +3.85% | +9.23% | +127.28% | 9.02 B USD | ||
| 987 |  ABVX Abivax SA - American Depositary Shares | 113.87 USD | -0.94% | -5.55% | -9.58% | +47.73% | 8.94 B USD | ||
| 993 |  CRNX Crinetics Pharmaceuticals, Inc. - Common Stock | 84.78 USD | +0.11% | +0.09% | +1.17% | +106.28% | 8.99 B USD | ||
| 1034 |  APGE Apogee Therapeutics, Inc. - Common Stock | 134.76 USD | +0.01% | +0.16% | +0.36% | +151.46% | 8.38 B USD | ||
| 1039 |  TGTX TG Therapeutics, Inc. - Common Stock | 53.62 USD | -1.20% | +9.54% | -6.42% | +81.95% | 8.21 B USD | ||
| 1045 |  IBRX ImmunityBio, Inc. - Common Stock | 7.55 USD | -3.08% | -1.31% | +3.99% | +226.84% | 8.00 B USD | ||
| 1079 |  RYTM Rhythm Pharmaceuticals, Inc. - Common Stock | 110.40 USD | +0.36% | -5.27% | +5.50% | +0.08% | 7.60 B USD |
Notizie Biotechnology Stocks
Deutsche Bank declassa argenx a Hold per valutazione
Perché il titolo di Monte Rosa Therapeutics scende oggi?
Il titolo di Biomea Fusion balza dopo il completamento dell’arruolamento nel trial sul diabete
Il titolo di Monte Rosa cala con l’avvio dello studio di fase 2 sul cancro alla prostata
H.C. Wainwright conferma il rating su Biomea Fusion dopo l’arruolamento nel trial
Il titolo azionario di Crinetics Pharmaceuticals raggiunge il massimo storico a 84,8 USD
La FDA estende la revisione di deramiocel di Capricor al 22 novembre
Gainers Biotechnology Stocks
 SKYE Skye Bioscience, Inc. - Common Stock | 2.11 | +653.57% |
 RCKTW Rocket Pharmaceuticals, Inc. - Warrant | 0.0038 | +280.00% |
 ENGNW enGene Therapeutics Inc. - Warrants | 0.4301 | +71.90% |
 NTRBW Nutriband Inc. - Warrant | 0.7500 | +50.00% |
 LSTA Lisata Therapeutics, Inc. - Common Stock | 1.98 | +27.74% |
 BMEA Biomea Fusion, Inc. - Common Stock | 1.68 | +22.63% |
 CELG-RT Bristol-Myers Squibb Company Celegne Contingent Value Rights | 0.1098 | +19.09% |
 ELOX Eloxx Pharmaceuticals, Inc. | 20.97 | +16.24% |
Losers Biotechnology Stocks
 OABIW OmniAb, Inc. - Warrant | 0.1700 | -40.27% |
 CINGW Cingulate Inc. - Warrants | 0.0060 | -34.07% |
 RGNX REGENXBIO Inc. - Common Stock | 8.14 | -24.07% |
 ASBPW Aspire Biopharma Holdings, Inc. - Warrant | 0.0131 | -17.09% |
 ADIL Adial Pharmaceuticals, Inc - Common Stock | 5.25 | -15.59% |
 APLMW Apollomics Inc. - Warrant | 0.0111 | -13.95% |
 BCTX BriaCell Therapeutics Corp. - Common Shares | 3.61 | -11.30% |
 YDESW YD Bio Limited - Warrants | 0.3642 | -11.17% |